Metraipolis › archive › dc_04cbb3212968
Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis — Europe PMC PMID:41550872
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41550872
- DOI
- 10.3389/fendo.2025.1742128
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T02:42:26.372Z
- SHA-256 of the archived text
589b80009f53ecbc33cd0c20fe4fae36ad47b8afd65462161ade41543b66668e- Stable URL of this page
https://metraipolis.com/documento/dc_04cbb3212968
How to cite
Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis — Europe PMC PMID:41550872 — Europe PMC (en), https://europepmc.org/article/MED/41550872 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04cbb3212968 (Metraipolis archive dc_04cbb3212968, sha256 589b80009f53ecbc33cd0c20fe4fae36ad47b8afd65462161ade41543b66668e)
BibTeX
@misc{dc04cbb3212968,
title = {Comparative efficacy and safety of different SGLT2 inhibitor-based combination strategies in HFrEF: a systematic review and network meta-analysis — Europe PMC PMID:41550872},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41550872},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04cbb3212968; sha256 589b80009f53ecbc33cd0c20fe4fae36ad47b8afd65462161ade41543b66668e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41550872. Agents can read the archived copy with the MCP tool read_document.